Privia Health Group (PRVA) Set to Announce Quarterly Earnings on Thursday

Privia Health Group (NASDAQ:PRVA - Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Privia Health Group to post earnings of $0.05 per share for the quarter. Privia Health Group has set its FY 2024 guidance at EPS.Individual that are interested in registering for the company's earnings conference call can do so using this link.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.02). Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business had revenue of $422.30 million during the quarter, compared to analysts' expectations of $411.50 million. During the same period last year, the company posted $0.06 EPS. Privia Health Group's revenue for the quarter was up 2.2% on a year-over-year basis. On average, analysts expect Privia Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Privia Health Group Stock Performance

NASDAQ:PRVA traded down $0.37 during midday trading on Thursday, reaching $18.36. 852,348 shares of the stock traded hands, compared to its average volume of 855,982. The company has a fifty day moving average of $18.45 and a 200 day moving average of $18.26. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $24.35. The stock has a market capitalization of $2.20 billion, a P/E ratio of 153.00, a PEG ratio of 4.01 and a beta of 0.76.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares of the company's stock, valued at approximately $4,583,763.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 14.20% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PRVA. Evercore ISI lowered their price target on shares of Privia Health Group from $23.00 to $20.00 and set an "outperform" rating for the company in a report on Tuesday, July 9th. Royal Bank of Canada reiterated an "outperform" rating and set a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. KeyCorp started coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an "overweight" rating and a $23.00 price objective for the company. Finally, Robert W. Baird upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of "Buy" and a consensus target price of $24.73.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.